Ileus in the ICU - ICUNOTES

Ileus in the ICU

Ileus is a functional, non-mechanical inhibition of intestinal propulsion resulting in impaired transit of gas, fluids, and enteral contents through the gastrointestinal tract without an anatomical obstruction.

Table of Contents

Pathophysiology

ICU ileus is multifactorial.

Cause	Mechanism
Neurogenic mechanisms	Critical illness causes ↑ sympathetic activity and ↓ parasympathetic (vagal) activity, resulting in reduced acetylcholine release, decreased intestinal contractions, and ileus.
Enteric nervous system dysfunction	Inflammation damages the myenteric and submucosal plexuses, causing weak contractions, poor coordination, and loss of propagating peristaltic waves, leading to impaired intestinal transit.
Inflammatory mechanisms	TNF-α, IL-1β, IL-6, nitric oxide (NO), prostaglandins, and reactive oxygen species (ROS) inhibit intestinal smooth muscle and enteric neurons, while promoting bowel wall edema and increased intestinal permeability, resulting in ileus.
Nitric oxide excess	Excess NO activates guanylate cyclase, increasing cGMP, which causes smooth muscle relaxation, reduced intestinal tone, and ileus. This mechanism is particularly important in septic shock.
Smooth muscle dysfunction	Inflammation reduces intracellular calcium influx, leading to decreased smooth muscle contractility, weak peristalsis, and delayed intestinal transit.
Interstitial cells of Cajal dysfunction	Critical illness damages the interstitial cells of Cajal (intestinal pacemaker cells), resulting in loss of slow-wave activity, absent coordinated contractions, and ileus.
Intestinal edema	Caused by aggressive crystalloid resuscitation, sepsis, capillary leak, and hypoalbuminemia. Edema separates smooth muscle fibers, impairing contraction and causing delayed intestinal transit.
Ischemia–reperfusion injury	Shock causes mesenteric hypoperfusion, followed by reperfusion and oxidative injury, leading to intestinal neuromuscular dysfunction and ileus.

Etiology

Electrolyte Disturbances

Electrolytes are essential for smooth muscle depolarization.
Hypokalemia,Hypomagnesemia,Hypocalcemia,Hypercalcemia,Hyponatremia,Hypophosphatemia

Drug-Induced Ileus

Drug	Mechanism
Opioids	μ-receptor activation
Morphine	↓ ACh release
Fentanyl	Delayed transit
Hydromorphone	Marked ileus
Sedatives	↓ CNS stimulation
Benzodiazepines	Reduced autonomic drive
Propofol	Indirect reduction in motility
Anticholinergics	Block muscarinic receptors
Vasopressors	Mesenteric vasoconstriction
Calcium channel blockers	Smooth muscle inhibition

Cause	Mechanism / Effect Leading to Ileus
Opioid-induced ileus	One of the most common causes of ileus in ICU patients. μ-opioid receptor stimulation → ↓ acetylcholine release → ↓ propulsive peristaltic contractions and ↑ non-propulsive (segmental) contractions → ↑ water absorption from intestinal contents → hard stool, delayed intestinal transit, and ileus.
Postoperative ileus	Surgical manipulation of the bowel activates an inflammatory response → macrophage activation → release of pro-inflammatory cytokines → enteric neural inhibition and smooth muscle dysfunction → transient ileus. Typically lasts 24–72 hours after most abdominal surgeries, but may persist longer after extensive bowel surgery or in the presence of complications.

Sepsis
Septic shock
Mechanical ventilation
High-dose opioids
Sedation
Electrolyte abnormalities
Abdominal surgery
Peritonitis
Pancreatitis
Trauma
Burns
Massive fluid resuscitation
Retroperitoneal hematoma
Mesenteric ischemia
Diabetes
Parkinson disease
Hypothyroidism
Chronic kidney disease
Liver failure
Prolonged fasting
Immobility

Clinical Features

Symptoms

Abdominal distension
Feeding intolerance
Nausea
Vomiting
Early satiety
Failure to pass stool
Failure to pass flatus
High gastric residuals
Recurrent aspiration

Signs

Distended abdomen
Tympanic percussion
Mild diffuse tenderness
Reduced bowel sounds (not reliable)
Increased intra-abdominal pressure (severe cases)

ICU-Specific Manifestations

Enteral nutrition intolerance
Recurrent vomiting
High nasogastric output
Repeated aspiration
Failure to achieve calorie targets
Increased ventilator requirements due to diaphragmatic splinting
Raised intra-abdominal pressure
Difficulty weaning from ventilator

Diagnosis

Routine bowel sounds are neither sensitive nor specific for diagnosing or excluding ileus.
Persistent ileus beyond 3–5 days (or worsening clinical status) should prompt reassessment for obstruction, ischemia, abscess, medication effects, or other complications.

Diagnosis is primarily clinical, supported by imaging to exclude mechanical obstruction and ischemia.

Laboratory Evaluation

Evaluate for reversible causes:

CBC
CRP
Lactate (ischemia)
Electrolytes (K, Mg, Ca, PO₄)
Renal function
Liver function
Thyroid function (if indicated)
Blood glucose
Drug review (opioids, anticholinergics)

Imaging

Plain Abdominal X-ray

Typical findings:

Diffuse gaseous distension of stomach, small bowel, and colon
Air present throughout the colon and rectum
Multiple dilated bowel loops
No discrete transition point

CT Abdomen with Contrast (Preferred if diagnosis uncertain)

Indications:

Severe pain
Fever
Leukocytosis
Elevated lactate
Persistent ileus (>3–5 days)
Concern for obstruction, perforation, ischemia, abscess

Findings in ileus:

Diffuse bowel dilation
No transition point
No obstructing lesion
Gas in colon and rectum

Ileus vs Mechanical Intestinal Obstruction

Feature	Ileus	Mechanical obstruction
Cause	Functional	Physical blockage
Pain	Mild, diffuse	Colicky, severe
Bowel sounds	Reduced/absent	Initially high-pitched, later absent
Distension	Diffuse	Variable
Vomiting	Common	Common
Flatus	Absent	Absent (complete obstruction)
Transition point on CT	No	Present
Gas in rectum	Usually present	Often absent in complete obstruction

Differential Diagnosis

Mechanical bowel obstruction
Acute colonic pseudo-obstruction (Ogilvie syndrome)
Mesenteric ischemia
Peritonitis
Toxic megacolon
Severe constipation/fecal impaction
Intra-abdominal abscess
Volvulus
Intussusception (rare in adults)

Acute Colonic Pseudo-obstruction (Ogilvie Syndrome)

A distinct entity characterized by isolated massive colonic dilation (especially cecum and ascending colon) without mechanical obstruction.

Feature	Generalized ileus	Ogilvie syndrome
Segment involved	Entire bowel	Colon predominately
Small bowel	Dilated	Usually normal/minimal
Cecal diameter	Mild–moderate	Often >10–12 cm
Perforation risk	Lower	High if cecum >12 cm or prolonged
First-line therapy	Correct causes, supportive	Supportive ± neostigmine ± colonoscopic decompression

Management

Management principles:

Identify and treat the cause.
Correct reversible factors.
Optimize supportive care.
Maintain nutrition.
Consider pharmacologic therapy in selected patients.
Escalate to intervention if complications develop.

Step 1: Treat the Underlying Cause

Control sepsis
Euvolemia
Correct electrolyte abnormalities
Treat endocrine disorders
Stop or reduce offending medications

Step 2: Reduce Opioids

Strategies:

Multimodal analgesia (acetaminophen, regional techniques where appropriate)
Minimize opioid dose
Avoid unnecessary continuous opioid infusions
Consider opioid antagonists in selected postoperative patients (e.g., alvimopan for specific elective bowel surgery settings; not routinely used in ICU)

Step 3: Correct Electrolytes

Electrolyte	Suggested target
Potassium	≥4.0 mmol/L
Magnesium	≥2.0 mg/dL (≈0.8 mmol/L)
Ionized calcium	Normal range
Phosphate	Normal range

Step 4: Gastric Decompression

Indications:

Persistent vomiting
Severe abdominal distension
Aspiration risk
High nasogastric output

Nasogastric drainage provides symptom relief but does not shorten ileus duration.

Step 5: Optimize Enteral Nutrition

Hold Feed temporarily and Treat the underlying cause then restart feed with liquids
Early enteral nutrition, even at trophic doses, is generally preferred over prolonged bowel rest when there is no contraindication.
Use trophic feeding rather than complete fasting when feasible.
Avoid unnecessary prolonged bowel rest.(because it can also promote ileus.)
Gastric residual volume alone should not be the sole reason to stop enteral nutrition; interpret it in conjunction with vomiting, abdominal distension, pain, and aspiration risk.

Step 6: Early Mobilization

Benefits:

Stimulates autonomic function
Improves GI motility
Reduces postoperative ileus duration
Decreases ICU-acquired weakness

Step 7: Prokinetic Therapy

Primarily helpful for upper GI dysmotility/gastroparesis, with limited evidence for generalized ileus therefore not recommended.

Step 8: Peripheral μ-Opioid Receptor Antagonists (PAMORAs)

Useful in opioid-induced ileus, especially postoperative settings.

Drug	Comments
Methylnaltrexone	ineffective in the MOTION trial,; may reverse opioid-induced gut hypomotility without affecting analgesia (does not cross the blood-brain barrier)
Naloxegol	Mainly for opioid-induced constipation
enteral naloxone	4-8 mg QID
Alvimopan	Approved for prevention of postoperative ileus after bowel resection; restricted use, not for routine ICU patients

Step 9: Surgical Consultation

Urgent evaluation is required if there is concern for:

Mechanical obstruction
Perforation
Peritonitis
Bowel ischemia
Toxic megacolon
Abdominal compartment syndrome

Monitoring

Monitor daily:

Parameter	Clinical significance
Abdominal girth	Progressive distension
Pain/tenderness	Ischemia or perforation
Passage of flatus/stool	Return of bowel function
NG output	Upper GI recovery
Enteral feed tolerance	Nutritional progression
Gastric residual volume (where measured)	Gastric emptying
Electrolytes	Correct reversible causes
Lactate	Suspected ischemia
Intra-abdominal pressure	If ACS suspected

Complications

Aspiration pneumonia
Ventilator-associated pneumonia
Severe malnutrition
Failure of enteral nutrition
Bacterial translocation
Sepsis
Increased intra-abdominal pressure
Abdominal compartment syndrome
Colonic perforation (especially with Ogilvie syndrome)
Prolonged mechanical ventilation
Increased ICU and hospital length of stay

Prevention

Early enteral nutrition when feasible
Avoid excessive opioids and anticholinergics
Daily sedation interruption when appropriate
Early mobilization
Goal-directed fluid therapy (avoid fluid overload)
Aggressive correction of electrolyte disturbances
Good glycemic control (avoid marked hyperglycemia)
Early recognition and treatment of sepsis
Judicious use of vasopressors with optimization of perfusion

References

Oh’s Intensive Care Manual. 9th ed.
Irwin and Rippe’s Intensive Care Medicine. 9th ed.
Textbook of Critical Care. 8th ed.
Marino PL. The ICU Book. 5th ed.
Harrison’s Principles of Internal Medicine. 22nd ed.
American Society for Enhanced Recovery (ASER) and Enhanced Recovery After Surgery (ERAS) Society guidelines on postoperative ileus and perioperative care.